Sales & Earnings In Brief: Merck, Glaxo, Prestige Brands, Teva, Mead Johnson
This article was originally published in The Tan Sheet
Executive Summary
Merck slates consumer unit decision for 2014; Glaxo consumer up 4% on oral care sales; Prestige Brands income plummets, Teva OTC growth continues; Mead Johnson rides Asian market growth; Church & Dwight boosts gummy marketing; and USANA builds on incentive program.